Amvis Holdings.Inc. (JP:7071)
:7071
Top Page
Amvis Holdings.Inc.
(7071)
Select Model
Select Model
Rating:62Neutral
Price Target:
¥444.00
▼(-6.33% Downside)
Action:ReiteratedDate:12/11/25
Amvis Holdings Inc. receives a moderate score due to strong revenue growth but faces challenges with declining profit margins and liquidity issues. The technical indicators suggest a bearish trend, while the valuation appears reasonable. The absence of earnings call and corporate events data limits further insights.
Positive Factors
Revenue Growth
Sustained top-line growth (≈12.6%) indicates enduring demand for Amvis's hospice and home medical services. Durable revenue expansion supports scale economics, capacity investments, and service network expansion, providing a foundation for longer-term profitability recovery if cost trends are addressed.
Negative Factors
Declining Profit Margins
Significant margin compression materially reduces internal cash generation and return on services. If persistent, falling gross and net margins undermine the firm's ability to fund operations, invest in care quality, or absorb reimbursement cuts, raising structural profitability risk over months.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained top-line growth (≈12.6%) indicates enduring demand for Amvis's hospice and home medical services. Durable revenue expansion supports scale economics, capacity investments, and service network expansion, providing a foundation for longer-term profitability recovery if cost trends are addressed.
Read all positive factors
Amvis Holdings.Inc. (7071) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥42.27B
Dividend Yield0.91%
Average Volume (3M)1.46M
Price to Earnings (P/E)10.7
Beta (1Y)1.14
Revenue Growth15.77%
EPS Growth-50.57%
CountryJP
Employees4,046
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)11.09
Shares Outstanding98,313,600
10 Day Avg. Volume829,320
30 Day Avg. Volume1,455,976
Financial Highlights & Ratios
PEG Ratio-0.32
Price to Book (P/B)1.63
Price to Sales (P/S)1.19
P/FCF Ratio-13.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥512.00Price Target Upside8.02% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)27.55
Revenue Forecast (FY)¥52.39B
Amvis Holdings.Inc. Business Overview & Revenue Model
Company Description
Amvis Holdings, Inc. provides nursing home, home nursing care, home care, in-home care support, and disability welfare services in Japan. It also offers consulting and other ancillary services. The company was founded in 2013 and is headquartered ...
How the Company Makes Money
Amvis Holdings Inc. primarily generates revenue by delivering hospice care services to patients in their homes or at designated care facilities. The company collaborates with healthcare providers and insurers to offer its services, which include p...
Amvis Holdings.Inc. Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
70
Positive
Cash Flow
55
Neutral
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.70B | 49.17B | 42.48B | 31.98B | 23.07B | 15.33B |
| Gross Profit | 16.71B | 14.79B | 17.05B | 13.26B | 9.67B | 6.29B |
| EBITDA | 11.31B | 8.94B | 12.46B | 9.83B | 6.97B | 4.34B |
| Net Income | 6.33B | 3.66B | 7.44B | 6.31B | 4.28B | 2.63B |
Balance Sheet | ||||||
| Total Assets | 82.68B | 84.16B | 71.99B | 55.69B | 41.85B | 31.99B |
| Cash, Cash Equivalents and Short-Term Investments | 11.81B | 10.83B | 8.87B | 12.13B | 11.34B | 11.19B |
| Total Debt | 40.32B | 40.15B | 31.75B | 23.05B | 17.43B | 12.75B |
| Total Liabilities | 47.52B | 48.02B | 38.77B | 29.17B | 21.39B | 15.65B |
| Stockholders Equity | 35.16B | 36.13B | 33.21B | 26.52B | 20.46B | 16.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.38B | -8.50B | -3.04B | -2.70B | -2.78B |
| Operating Cash Flow | 0.00 | 6.03B | 7.48B | 6.80B | 4.42B | 2.58B |
| Investing Cash Flow | 0.00 | -10.43B | -16.83B | -10.31B | -7.75B | -5.78B |
| Financing Cash Flow | 0.00 | 6.37B | 6.08B | 4.30B | 3.49B | 11.05B |
Amvis Holdings.Inc. Technical Analysis
Negative
474.00
Price Trends
471.20
Negative
467.43
Negative
514.09
Negative
Market Momentum
-11.13
Negative
43.64
Neutral
67.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7071, the sentiment is Negative. The current price of 474 is above the 20-day moving average (MA) of 436.15, above the 50-day MA of 471.20, and below the 200-day MA of 514.09, indicating a bearish trend. The MACD of -11.13 indicates Negative momentum. The RSI at 43.64 is Neutral, neither overbought nor oversold. The STOCH value of 67.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7071.
Amvis Holdings.Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥45.40B | 15.80 | 20.80% | 1.77% | 16.49% | 3.34% | |
72 Outperform | ¥43.70B | 11.61 | ― | 2.63% | 0.30% | -31.28% | |
68 Neutral | ¥105.73B | 16.02 | ― | 2.47% | 1.86% | 1370.48% | |
62 Neutral | ¥42.27B | 10.69 | ― | 0.91% | 15.77% | -50.57% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
45 Neutral | ¥6.41B | -88.53 | ― | 1.41% | 18.03% | -11.68% |
* Healthcare Sector Average
JP:7071
Amvis Holdings.Inc.
430.00
-21.01
-4.66%
JP:6099
Elan Corp.
751.00
44.58
6.31%
JP:6062
Charm Care Corporation
1,340.00
158.93
13.46%
JP:6197
Solasto Corp.
1,116.00
684.70
158.75%
JP:7061
Japan Hospice Holdings Inc.
761.00
-783.77
-50.74%
Amvis Holdings.Inc. Corporate Events
Amvis Finalizes New Stock Acquisition Rights for Directors and Employees
Mar 3, 2026
Amvis Holdings, Inc. has finalized the issuance details of its sixth and seventh series of paid stock acquisition rights to directors and employees. The move underscores the company’s continued use of stock-based incentives to foster long-te...
Amvis Issues Performance-Linked Stock Options to Drive Growth in Medical Support Business
Feb 15, 2026
Amvis Holdings has approved the issuance of paid stock acquisition rights as stock options to its directors and employees, aiming to boost motivation, align interests with shareholders, and support medium- to long-term growth in its comprehensive ...
Amvis Major Shareholder Grants Call Options to Align Insiders With Long-Term Value
Feb 15, 2026
Amvis Holdings’ major shareholder, IDEA Capital Co., Ltd., wholly owned by CEO Keiichi Shibahara, has agreed to grant call options over up to 1.1 million Amvis shares to 16 eligible insiders, including directors and employees of the company ...
Amvis Posts Q1 Sales Growth but Profit Declines, Keeps FY2026 Outlook and Dividend Plan
Feb 13, 2026
Amvis Holdings reported consolidated net sales of ¥12.94 billion for the first quarter ended December 31, 2025, up 9.9% year on year, while EBITDA and profit attributable to owners of parent declined 8.6% and 19.7% respectively, reflecting in...
Amvis Completes Treasury Share Disposal for Employee Restricted Stock Compensation
Feb 2, 2026
Amvis Holdings has completed the payment procedures for the disposal of 578,000 shares of its treasury stock as restricted share compensation to 22 employees of the company and its subsidiary, at a disposal price of 468 yen per share for a total o...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.